Sci-Tech News Today
SEE OTHER BRANDS

The latest news on science and technology

Sci-Tech News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.

Press releases published on May 13, 2025

Delinea Begins FedRAMP High Authorization Process for Secret Server

Delinea Begins FedRAMP High Authorization Process for Secret Server

SAN FRANCISCO, May 13, 2025 (GLOBE NEWSWIRE) -- Delinea, a pioneering provider of solutions for securing human and machine identities through centralized authorization, has initiated the FedRAMP High authorization process for Secret Server, an industry- …

Candel Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Candel Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Announced accepted oral presentation of positive phase 3 randomized placebo controlled clinical trial results of CAN-2409 (aglatimagene besadenovec) in localized prostate cancer at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting …

Plotly Honored as Bronze Stevie Award Winner In 2025 American Business Awards

Plotly Honored as Bronze Stevie Award Winner In 2025 American Business Awards

MONTREAL, May 13, 2025 (GLOBE NEWSWIRE) -- Plotly, the premier Data App platform for Python, has been named a Bronze Stevie® Award winner in the Artificial Intelligence/ Machine Learning Solution – Other category in The 23rd Annual American Business Awards …

FTC Solar to Participate in Upcoming Investor Conferences

FTC Solar to Participate in Upcoming Investor Conferences

AUSTIN, Texas, May 13, 2025 (GLOBE NEWSWIRE) -- FTC Solar, Inc. (Nasdaq: FTCI), a leading provider of solar tracker systems, software and engineering services, today announced that members of its management team, including CEO Yann Brandt, are scheduled to …

Werewolf Therapeutics to Participate in Hanson Wade’s 6th Annual Cytokine-Based Drug Development Summit

Werewolf Therapeutics to Participate in Hanson Wade’s 6th Annual Cytokine-Based Drug Development Summit

WATERTOWN, Mass., May 13, 2025 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate …

Design Therapeutics to Participate in 2025 RBC Capital Markets Healthcare Conference

Design Therapeutics to Participate in 2025 RBC Capital Markets Healthcare Conference

CARLSBAD, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in a …

Artelo Biosciences Provides Business Update and Reports First Quarter 2025 Financial Results

Artelo Biosciences Provides Business Update and Reports First Quarter 2025 Financial Results

SOLANA BEACH, Caif., May 13, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, …

Cidara Therapeutics to Participate in Two Upcoming Investor Conferences

Cidara Therapeutics to Participate in Two Upcoming Investor Conferences

SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that company management will …

Erasca Announces Early Clinical Advancement and Prioritization of RAS-Targeting Franchise Coupled with More than 3 Years of Projected Cash Runway

Erasca Announces Early Clinical Advancement and Prioritization of RAS-Targeting Franchise Coupled with More than 3 Years of Projected Cash Runway

IND cleared for pan-RAS molecular glue ERAS-0015 and IND submitted for pan-KRAS inhibitor ERAS-4001, both ahead of schedule; Phase 1 monotherapy data for both programs expected in 2026 Meaningful extension of cash runway guidance from H2 2027 to H2 2028 …

Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2025 Financial Results

Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2025 Financial Results

Continued Progress in Ongoing Late-Stage Netherton Syndrome Studies Announced Positive Clinical Data for Adult and Pediatric Netherton Patients Provided Clear Visual Evidence of QRX003 Mechanism of Action Patent Portfolio Expanded to Support Pipeline …

Viasat Selected by U.S. Space Force for Phase 2 of Enterprise Space Terminal Program

Viasat Selected by U.S. Space Force for Phase 2 of Enterprise Space Terminal Program

CARLSBAD, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Viasat, Inc. (NASDAQ: VSAT), a global leader in satellite communications, today announced it was selected by the U.S. Space Force’s (USSF) Space Systems Command (SSC) for the second phase of its Enterprise …

Microchip Opens Registration for its 25th Annual MASTERs Conference in Scottsdale, Arizona

Microchip Opens Registration for its 25th Annual MASTERs Conference in Scottsdale, Arizona

CHANDLER, Ariz., May 13, 2025 (GLOBE NEWSWIRE) -- Microchip Technology (Nasdaq: MCHP) today announces that registration is now open for its MASTERs Conference in North America, the premier technical training event for embedded design engineers. This year …

Reviva to Participate in the A.G.P. Healthcare Company Showcase

Reviva to Participate in the A.G.P. Healthcare Company Showcase

CUPERTINO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central …

Spaceback Introduces CTV Launchpad for Advertisers

Spaceback Introduces CTV Launchpad for Advertisers

NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Spaceback has released CTV Launchpad for advertisers, bringing the magic of social to CTV advertising. CTV Launchpad is a new, easy-to-use platform that unlocks social creative and more for advertisers of any size …

Avadel Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference

Avadel Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference

DUBLIN, May 13, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the H.C. …

Advanced Technology International Acquires Carrot

Advanced Technology International Acquires Carrot

SUMMERVILLE, S.C., May 13, 2025 (GLOBE NEWSWIRE) -- We are excited to announce that effective March 31, 2025, Advanced Technology International (ATI), a South Carolina based 501(c)3 public service nonprofit, acquired the assets of The Common Pool, LLC, dba …

Lexis+ AI Fuels $30M Revenue Growth in Law Firms, New Study Finds

Lexis+ AI Fuels $30M Revenue Growth in Law Firms, New Study Finds

NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- LexisNexis® Legal …

Algorhythm Holdings Announces Major Fleet Expansion for SemiCab India

Algorhythm Holdings Announces Major Fleet Expansion for SemiCab India

SemiCab India Adds Additional Truck Capacity with Expansion to Generate Up to $23 Million in Annual Revenue Fort Lauderdale, FL, May 13, 2025 (GLOBE NEWSWIRE) -- Algorhythm Holdings, Inc. (“Algorhythm”) (NASDAQ: RIME) – an AI technology and consumer …

red violet to Present at the 25th Annual B. Riley Securities Investor Conference

red violet to Present at the 25th Annual B. Riley Securities Investor Conference

BOCA RATON, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- Red Violet, Inc. (NASDAQ: RDVT), a leading analytics and information solutions provider, today announced that it will present at the 25th Annual B. Riley Securities Investor Conference being held May 21-22 …

ALX Oncology to Host R&D Webcast Event Highlighting its Novel EGFR Targeting Antibody-Drug Conjugate, ALX2004, on May 20, 2025

ALX Oncology to Host R&D Webcast Event Highlighting its Novel EGFR Targeting Antibody-Drug Conjugate, ALX2004, on May 20, 2025

SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service